ArticlePDF Available

Fractional Carbon Dioxide Laser: Optimizing Treatment Outcomes for Pigmented Atrophic Acne Scars in Skin of Color

Authors:

Abstract and Figures

Dark skin type has high propensity to acne scarring and is often complicated by persistent erythema or pigmentation at the base. Fractional lasers are available for the longest period and are able to improve most atrophic acne scars. Often pigmented scar bases and dark skin types limit the use of aggressive laser parameters. Long pulse mode is preferred over short pulse to prevent epidermal damage; low fluence is chosen versus high fluence and low density versus high density. Repeated treatments are needed to minimize complications and optimize results; all these must be achieved through a controlled stage of inflammation. Interventional priming with chemical peels and laser toning before ablative fractional carbon dioxide laser helps to reduce photodamage, recent tan, and pigment at scar base, thus minimizing the risk of post-inflammatory hyperpigmentation. Multiple recent literature evidence validates the combinations to optimize outcomes in atrophic acne scars as discussed in this review article.
Content may be subject to copyright.
Access this article online
Quick Response Code:
Website:
www.jcasonline.com
DOI:
10.4103/JCAS.JCAS_171_18
85
Address for correspondence: Dr. Shehnaz Z. Arsiwala,
Renewderm Skin Hair Lasers Aesthetics Centre,
Nesbit Road, Mazgaon, Mumbai 400010,
Maharashtra, India.
E-mail: drshenaz@gmail.com
© 2019 Journal of Cutaneous and Aesthetic Surgery | Published by Wolters Kluwer - Medknow
This is an open access journal, and articles are distributed under the terms of the
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
others to remix, tweak, and build upon the work non-commercially, as long as
appropriate credit is given and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
How to cite this article: Arsiwala SZ, Desai SR. Fractional carbon
dioxide laser: Optimizing treatment outcomes for pigmented atrophic
acne scars in skin of color. J Cutan Aesthet Surg 2019;12:85-94.
Symposium: Lasers Review Article
Fractional Carbon Dioxide Laser: Optimizing Treatment
Outcomes for Pigmented Atrophic Acne Scars in Skin of Color
Shehnaz Z. Arsiwala, Swasti R. Desai1
Renewderm–Skin Hair Lasers Aesthetics Centre, Mumbai, Maharashtra, India, 1Consultant dermatologist, Janta hospital, Surat, Gujarat, India
Abstract
Dark skin type has high propensity to acne scarring and is often complicated by persistent erythema or pigmentation at the base.
Fractional lasers are available for the longest period and are able to improve most atrophic acne scars. Often pigmented scar bases
and dark skin types limit the use of aggressive laser parameters. Long pulse mode is preferred over short pulse to prevent epidermal
damage; low fluence is chosen versus high fluence and low density versus high density. Repeated treatments are needed to minimize
complications and optimize results; all these must be achieved through a controlled stage of inflammation. Interventional priming
with chemical peels and laser toning before ablative fractional carbon dioxide laser helps to reduce photodamage, recent tan, and
pigment at scar base, thus minimizing the risk of post-inflammatory hyperpigmentation. Multiple recent literature evidence validates
the combinations to optimize outcomes in atrophic acne scars as discussed in this review article.
Keywords: Combination therapies, fractional ablative lasers, pigmented atrophic acne scars, skin of color
IntroductIon
Acne scars are a sequela of deep, persistent, and
inflammatory acne. Individuals who scar after acne have
specific biochemical characteristics in their skin, which
predispose them. Managing acne scars is a challenge, and
treating pigmented acne scars in skin of color multiplies
this challenge.
Multiple treatment modalities for surgical to nonsurgical,
peels to lasers and energy-based devices, and ablative to
nonablative fractional and nonfractional are available in our
armamentarium to improve acne scars [Table 1]. Of all the
various modalities available, fractional lasers are available for
the longest period and are able to improve most atrophic acne
scars. Combination of technologies when used sequentially
or rotationally improves outcome, thus minimizes side effects.
The results are better lasting. Multiple recent literature
evidence validates combinations to optimize outcomes in
atrophic acne scars as discussed in this review article.
Acne scars morphology
Progressive scarring with acne clearance is a known
phenomenon. Scars have various morphological
characteristics and vary in size, shape, and depth, and
are thus graded in various types as rolling, boxcar, and
ice pick types. Goodman and Baron classification for
acne scars is a standard tool for assessing atrophic scars
and are graded from types 1–4.[1] Clinically, in addition to
grades of atrophic scars, one needs to assess their stage
of development, early scars may be erythematous, as they
progress they may get purplish or pigmented. Pigmented
scars are a prominent feature in Indian skin, which
belongs to Fitzpatrick types 3–5[2,3] [Figures 1 and 2].
Acne scars in an individual maybe of mixed types and
may be distributed pan-facially with variable appearance
in different face zones. Dark skin type has high propensity
to acne scarring and is often complicated by persistent
erythema or pigmentation at the base.[4] Initial erythema
may be replaced by purplish base, which may later
pigment. Coexisting active acne may be superimposed[3]
[Figure 3].
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acne scars
86 86 Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019
Pathogenesis for acne scars
Scientific studies highlight that prolonged inflammation
leads to scarring and if the inflammation is persistent then
scarring may be progressive.[5] High-grade acne leads to high
degree of inflammation as seen with papulonodular and
cystic acne; dermal insult to tissue metalloproteinases is
more long lasting and results in a decrease of tissue leading to
atrophic scars. If the inflammation is nonspecific but robust
and generates early angiogenesis with a quick resolution,
there will be minimal scars. In all those cases, where more
specific, ineffectual, but prolonged inflammatory response
and angiogenesis are seen are the scarrers. Involvement of
epidermis, upper, or deep reticular dermis defines the depth of
acne scars and also the treatment choice.[5] Mild-to-moderate
scars involving epidermis and papillary dermis respond to
resurfacing laser or other technologies [Table 1], whereas the
deep scars involving reticular dermis require more aggressive
or combination modalities.[6]
Clinical characteristics and assessment of pigmented
acne scars
Fitzpatrick skin types 3–6 are predisposed to more inflamed
acne and hence more pigmentation (post-inflammatory
hyperpigmentation [PIH])[3,4,7] than erythema. This results
in pigmented acne and acne scars and has been proven
histologically.[2,7-9] Histological studies in post-acne
pigmented macules revealed epidermal melanin granules
and dermal melanophages infiltration up to the reticular
dermis, along with foreign body granulomas and giant
cells.[9,10] Callender and Davis[4] have postulated that this
heightened inflammatory response may be a major reason
that African Americans with even mild-to-moderate
acne still develop hyperpigmented macules, which were
studied by histopathology, showing dilated, distorted,
keratin-filled follicles consistent with comedones and
patchy chronic inflammation.[1,8] Kligman and Mills[11]
described comedogenicity of cosmetic products applied on
face because of the presence of certain ingredients in their
formulas also called as acne cosmetica. In skin of color
with acne lesions, increased use of cosmetic products may
inadvertently be a causative factor for acne and PIH.[11]
A thick stratum corneum, large melanosomes, and
a thick dermis with abundant fibroblasts constitute
morphological features in a dark skin prototype 4–6.[9]
According to the author, interventional therapies
for skin of color revolve around achieving optimum
outcome, creating no pigmentary sequelae. Aggressive
modalities are hence replaced by less aggressive, safer
options. Repeated treatments are needed to minimize
complications and optimize results; all these must be
achieved through a controlled stage of inflammation as
inflammatory mediators play a large role in progressive
scars. Features that influence choice of therapy and
predictability of outcomes include the presence of active
acne, degree of erythema or pigmentation at base, scar
type and grading, skin stretch test where stretchable scars
have better improvement than adherent ones, which need
subcision.
Principle of fractional photothermolysis
Laser resurfacing delivers monochromatic light into the
scars and subsequent heat initiates collagen injury and
neocollagenesis.[12]
Figure 1: Pigmented macular atrophic acne scars Figure 2: Pigmented atrophic acne scars (grade 2)
Table 1: Interventional modalities for atrophic acne scars
Grade 1 atrophic
acne scars—macular
Peels, microdermabrasion, dermaroller,
nonablative lasers
Grade 1 atrophic
pigmented scars
Peels, dermaroller, nonablative lasers, QS laser
toning with DRT, fractional erbium/
CO2 lasers. Transepidermal delivery of growth
factors, vitamin C
Grade 2 atrophic
scars
Peels and DRT, QSLT and DRT, peels and
fractional erbium/CO2 lasers, QSLT and
fractional lasers, all of the above with PRP
Grade 3 atrophic
scars
Laser combinations ablative and nonablative,
erbium and CO2 fractional, with peels/PRP,
microneedle RF with PRP, with HA
Grade 4 atrophic
scars
Subcision with fractional CO2, with peels/
PRP, microneedle RF with PRP, combination
with transepidermal drug deliveries, with HA
DRT=Dermaroller therapy, RF=Radio Frequency, HA=Hyaluronic
Acid, QSLT=Q- Switched laser toning
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acnescars
Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019 87
Manstein et al.[13] introduced the concept of fractional
photothermolysis (FP). Their FP device tends to emit
laser beam into pixilated manner, producing array of
microthermal zones (MTZ) and creating microscopic
channels by thermal injury to the skin.[13]
In contrast to ablative devices, which produce uniform and
confluent patch by ablative epidermal and dermal injury,
fractional resurfacing (FR) produces MTZ by ablating
epidermal and dermal tissue in regularly spaced channels on
the skin surface leaving intervened skin untouched, which
leads to faster healing of ablated columns of tissue.[14,15]
The depth, density, and size of microthermal columns
depend on the type of device and parameters used, that
is, fluence, wavelength, density, and stacking of the pulse.
Astudy reported that in atrophic acne scars with a density
of 100 spots/cm2, an energy of 100 mJ would reach a
depth of 1236 µm with a coverage of around 8.6%.[14]
Microthermal channels have epidermal and dermal debris,
which get eliminated by transepidermal elimination.[14-16] It
is followed by stimulation of reepithelialization and repair
mediated through adjacent intact tissue, and thermally
ablated channels get repopulated by fibroblast-derived
neocollagenesis. Healing is faster as the large percentage of
intervening area is not affected. Four to six treatments are
performed, each treatment at the interval of 30–45days.
Neocollagenesis is significant after 3months and continue
for 6months.[17]
Advantages of FP include the following:
1. Reduced postprocedural erythema and edema
2. Less chances of PIH as water in collagen is the
chromophore
3. Less downtime
4. Better patient compliance and acceptance
photothermolysis
Ablative fractional resurfacing with CO2 laser
The wavelength of CO2 lasers is 10,600 nm. It has high
affinity for water, which is the chromophore and targets
20–60µm depth of epidermal and papillary dermal layers,
the surrounding zone of thermal damage extends up to
20–50µm.[13] MTZ are formed and are variable according
to the fluence used and the depth of penetration achieved.
Thermal injury generates coagulation and denaturation of
collagen and reepithelialization ensues. Fractional ablation
of epidermis and dermis is enabled thus reepithelisation
is facilitated from the surrounding non ablated skin and
appendages.
Ablative fractional resurfacing with CO2 laser (AFRCL)
is evidenced based for resurfacing atrophic acne scars
of moderate-to-severe variety [Table 2]. Multiple studies
Figure 3: Erythematous acne scars (grade 3) with few active acne lesions. (A and B) before, (C and D) after peels and AFRCL
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acne scars
88 88 Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019
support the efficacy of AFRCL for atrophic acne scars.
Various parameters, densities and fluence levels, modes,
and the respective outcomes were studied by multiple
authors and are enumerated in Table 2.
Often pigmented scar bases and dark skin types limit the
use of aggressive laser parameters. Long pulse mode is
preferred over short pulse to prevent epidermal damage,
low fluence is chosen versus high fluence and low density
versus high density.[18] Though this becomes safer to prevent
PIH in dark skin, it results in less depth of penetration
and less deeper thermal effects on acne scars.[3] Topical
priming agents are often insufficient to prevent PIH when
optimum parameters need to be used. Fractional lasers do
not correct pigmentation at the base of scars.[3]
According to the author’s experience, while conducting
AFRCL for moderate-to-severe atrophic scars, dual
modes of operation in the same system enable better
treatment outcome where the stack mode enables high-
fluence laser ablation of individual scars, and the dynamic
mode with mosaic pattern of beam delivery enables
textural improvement of the unscarred surrounding skin.
At higher fluence and low average density with a moderate
peak power, one can safely treat deep scars focally in static
mode. With a low fluence and high average density and
larger scan size, one can treat surrounding skin and rest of
the face for textural improvement.
The conclusions drawn on the basis of the various studies
[Table 2] were that ablative fractional resurfacing (AFR)
improved the depth and appearance of acne scars by
as much as 50% after a series of four to five treatments
performed on a monthly basis. All studies reported textural
improvement. Ahigh-fluence, low-density setting has been
shown to be more efficacious than a low-fluence, high-
density setting. For deep scars one can selectively treat
with small spot size and rest of face can be treated with
large spot size and low fluence for textural improvement
thus enabling dual mode treatment pattern to improve
overall outcome for atrophic acne scars.[16,18,22]
Furthermore, FP significantly improved acne scars with
PIH as well as scar volume. Improvement was better
appreciated after 6months of sessions as neocollagenesis
sets in. As with all laser treatments in skin of color,
treatment levels should be increased with caution.[16,18,22]
Special considerations for pigmented acne scars in skin
of color
Priming: Before embarking on laser therapy for atrophic
pigmented acne scars, one must ensure resolution of active
acne and adequate priming [Figures 3–6]. As pigmented
acne scars limit the use of high-fluence parameters, priming
is mandatory, especially in dark-skin prototypes. Priming
reduces wound healing time and decreases the risk of PIH,
it determines patient tolerance and establishes patient
compliance. Added antioxidants/anti-inflammatory
cosmeceuticals are the new focus in priming as are oral
sunscreens, antioxidants as systemic priming agents. All
Table 2: Studies for AFRCL on atrophic acne scars
Fractional laser/
carbon dioxide laser
Type of scar Parameters Outcome
Majid and Imran[19] (60
Indian patients)
Atrophic acne
scars
Fractional carbon dioxide
Laser as monotherapy
Excellent response was observed in 26 patients (43.3%),
whereas 15 (25%) and 19 patients (31.7%) showed a good
and poor response, respectively. Rolling and supercial
boxcar scars responded the best, whereas pitted scars
responded the least to fractional laser monotherapy.
Chapa etal.[20] (13
patients types 1–4)
Moderate-to-severe
atrophic acne scars
Higher pulse and larger microscopic
treatment zones
Signicant improvements of 26%–50% on a quartile scale
and improved scar depths of 66.6%.
Drawback: erythema, which resolved within 1month in
most patients
Jung etal.[18] (10 Korean
patients)
Atrophic acne
scars
Split face, Evaluator blinded, lower
uence, high density vs. higher uence,
low density
A high-uence, low-density setting has been shown to be
more efcacious than a low-uence, high-density setting
Manuskiatti etal.[21] (13
Asian patients) with
Fitzpatrick skin type 4
Atrophic scars in
Asian patients
Four treatment sessions over a 7-week
duration
Scar smoothness and volume improved, 25% and 50%
improvement 6months after treatment
Cho etal.[22] (20 Korean
patients)
Atrophic acne
scars
Selected deep scars, small spot size,
coagulation, and larger spot size for rest
of face for rejuvenation, 3months
Moderate-to-good improvement in deep scars and
improved rejuvenation
Hedelund etal.[23] (13
patients)
Atrophic acne
scars
Low-pulse energies of 48–56 mJ
accounted for the modest results
Modest improvement in scar texture and scar atrophy
Trelles etal.[16] (40
patients types 2–4)
Atrophic acne
scars
Single session, medium settings (2 Hz,
30 W, 60 mJ) were used, and two passes
were made for dark skins and degree
1 wrinkles. High settings (2 Hz, 60 W,
120mJ) were used, and three passes
were made
Treatment improved, wrinkle aspect and scar condition,
and no patient reported adverse effects or complications,
irrespective of skin type
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acnescars
Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019 89
these enable ultraviolet damage protection and prevent
pigment darkening and hence prepare theskin.
In cases of pigmented acne scars, as pigment at base of
scar is a limitation for high-fluence laser therapy and often
only topical priming agents are insufficient to alleviate
pigmentation adjuvant therapies (such as chemical
peeling) [Figure 3A–D, Figure 5A–D], low-fluence QS
laser toning acts as interventional priming, the concept
being to make the scars as skin colored as possible.[2,7,24]
Optimizing outcomes, advantages of peels/laser toning as
priming agents:
1. Adjunctive therapy
2. Pigment elimination, textural improvements, and
photodamage correction
3. Improve compliance and tolerance
4. Adherence to therapy and enables acne and squeal
monitoring
5. Synergistic to fractional ablative lasers in treating
atrophic scars
6. Enhances outcome to laser resurfacing
7. Used for acne and scars in males as skin is more
seborrheic and thicker
Combinations rationale for combination therapies
Achieving synergism with multiple adjunctive therapies
when combined shortens time interval to achieve results
with albeit safer parameters [Figures 3–6]. Combination
of technologies when used sequentially or rotationally
improves outcome, thus minimizes side effects. The results
are better lasting. The evidence from multiple recent
literature validates combinations to optimize outcomes in
atrophic acne scars. Table 3 shows the possible combinations.
Subcision
Adherence of rolling acne scars can be addressed
with subcision before laser resurfacing sequentially or
rotationally. It is less suited for ice pick and deep boxcar
scars.[26] An 18- or 20-gauge needle breaks fibrous strands,
holding the scar down, and elevates the scar and subcision
also stimulates and produces neocollagen formation.[26,28]
Multiple treatments may be required to achieve an
optimal outcome.[25-30] Combination of ablative fractional
and nonablative lasers is another rationale for reducing
complications and optimizing outcomes in skin of color
as studied by Kim and Cho[31] who combined it in a series
of 20 Asian patients (skin prototypes 4–6) with atrophic
facial acne scars. Good outcome was reported in scars and
texture and pigment compared to stand-alone AFR.[31]
Combination with Quality- Switched (QS) neodymium-doped
yttrium aluminum garnet (Nd:YAG) quasi-pulse nonablative
and/or QS Nd:YAG low-fluence laser toning[24] is another
combination with good synergism with AFRCL and is widely
used for pigmented atrophic acne scars [Figure 4A–D].The
Figure 4: (A, B) Pigmented erythematous acne scars before. (C, D) Pigmented erythematous acne scars after nonablative quasi pulse Nd:YAG laser
with AFRCL
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acne scars
90 90 Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019
Figure 5: (A, B) Erythematous acne scars grade 3, with few active acne lesions. (C, D) Erythematous acne scars grade 3 after peels and AFRCL
Figure 6: (A, B) Pigmented acne scars grade 3. (C, D) Pigmented acne scars after AFRCL with PRP
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acnescars
Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019 91
author uses the low-fluence laser toning before AFRCL as
an interventional priming method.
Safety and efficacy of AFR with CO2 laser are well
documented, a few studies also elaborate longevity of
the results from 1–2years. Ortiz et al. reported clinical
maintenance of the improvement in up to 74% among
10 patients.[32] The presence of inflammatory mediators
and heat shock protein 47 in first 3 months after FR
may attribute better appearance of improvement initially
compared to that in long term, according to this study as
shown by certain histologic studies.
Platelet-rich plasma
Autologous platelet-rich plasma (PRP) injected or
delivered into the scars after laser treatment enriches
the skin with potential bioactive growth factors and
chemokines released on platelet activation and enables
faster wound repair.[33] Studies indicate faster reduction
of post-laser edema, erythema, and PIH.[34] Synergizing
AFR with PRP is also known to actively reduce atrophic
acne scarring[33] [Table 4] [Figure 6A–D].
Autologous growth factors and secretory proteins,
chemokines, and cytokines released on platelet
activation facilitate wound repair and rejuvenation
in cosmetic dermatology, they act by stimulation of
dermal fibroblast proliferation and increase type
Icollagen synthesis.[8,13,35] Both topical and intradermal
PRP injections have been studied with variable results
for acne scars.[9,36,37] Fractional CO2 laser creates thermal
wounds on the skin and also facilitates absorption
gradient by a damaged epidermis and PRP is known
to aid in wound healing, combining the two increases
therapeutic outcome.[9,36,38-40]
Tips for treating pigmented acne scars with AFRCL are
as follows:
Use the fluence judiciously in darker skin (Fitzpatrick
skin types 3–6). Parameters to be chosen with caution
as chances of post-inflammatory pigmentation are
very high.
• Priming with lightening agents and sunscreen should
be started at least 3–4 weeks before first treatment, oral
sunscreens can be added.
Table 3: Synergistic possibilities in combination therapies
for pigmented acne scars
Study Method Outcome
Split-face trail
of 16patients by
Faghihi etal.[37],
two sessions
One side treated with
fractional CO2 laser alone
and the other side treated
with a combination of
fractional CO2 laser with
intradermal PRP
Better results and
lesser side effects
with combination
Gawdat etal.,[41]
30patients, split
face, 3sessions,
6months
PRP injected and applied
after AFRCL vs. AFRCL
alone
Combination
better score with
less pain after
therapy
Abdel Aal etal.,[39]
20patients
AFRCL vs. AFRCL with
topical PRP
Better results
with combination
Table 4: Studies of AFRCL combined with PRP
Interventional
modality Atrophic scar response
Peels Improves acne, seborrhea, pigmentation,
texture, and grade 1–2 acne scars
Microdermabrasion Improves texture, grade 1 scars
Subcision Adherent scars—boxcar scars
Microneedling Types 1 and 2 scars
Lasers—nonablative Types 1–3 rolling scars
Lasers fractional
erbium
Types 1 and 2 scars
Lasers fractional CO2Types 1–4 scars
Lasers—QS Nd:YAG Pigmentation in QS mode and types 1 and 2
scars in quasi pulse mode
Microneedle RF Types 2–4 scars
PRP Adjuvant for better healing and
neocollagenesis
Transepidermal drug
delivery
For hydration, pigmentation, repair, and
textural improvement
RF = Radio frequency
Chart 1: Algorithm for treating pigmented acne scars
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acne scars
92 92 Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019
• Interventional priming with chemical peels and laser
toning before AFR helps to reduce photodamage,
recent tan, and pigment at scar base, thus minimizing
risk of PIH after AFR.
Low-fluence, high-density treatments are safer for
pigmented acne scars.
History of oral isotretinoin and keloids formation to
be elicited.
1. Oral isotretinoin should be discontinued at least
6–12 months before resurfacing procedures.[42]
This is recommended based on earlier reports of
keloid formation and atypical scar formation after
treatment with argon lasers and dermabrasion,
which are more invasive and ablative procedures.[42,43]
Some of the recent studies suggest the safety of
different procedures such as laser hair removal and
dermabrasion in patients recently treated with oral
isotretinoin.[44]
2. Postprocedural delivery of vitamin C, antioxidants
and emollients, and PRP acts to facilitate better
healing, rejuvenation.
3. Postprocedural emollients and sunscreen with
antiviral and antibacterial prophylaxis when
indicated minimize side effects.
Combinations with subcision, topical drug delivery, PRP,
nonablative, and QS Nd:YAG lasers act by synergism and
facilitate safer treatments and better outcomes. Charts1–3
show the algorithm of combination treatments.
Chart 2: Algorithm for acne scars with AFRCL and PRP
Chart 3: Algorithm for combining with subcision and PRP
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acnescars
Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019 93
conclusIon
The management of acne vulgaris and consequent scarring
is a long-term process that must be individualized to each
patient. Often we are dealing with patients who have coexisting
active acne with acne scars. Problems while handling skin of
color need great consideration while choosing aggressive
modalities of treatment to avoid complications. For Indian
patients, the current trends revolve around less aggressive
and combination of various treatment modalities.
Declaration of patient consent
The authors certify that they have obtained all appropriate
patient consent forms. In the form the patient(s) has/have
given his/her/their consent for his/her/their images and
other clinical information to be reported in the journal.
The patients understand that their names and initials will
not be published and due efforts will be made to conceal
their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
references
1. Goodman GJ, Baron JA. Postacne scarring: a qualitative global
scarring grading system. Dermatol Surg 2006;32:1458-66.
2. Kubba R, Bajaj AK, Thappa DM, Sharma R, Vedamurthy M,
DharS, etal.; Indian Acne Alliance (IAA). Acne in India: guidelines
for management—IAA consensus document. Indian J Dermatol
Venereol Leprol 2009;75:1-62.
3. Shehnaz AZ. Chemical peels for post acne hyperpigmentation in
skin of color. Pigmentary Disorders 2015;2:162.
4. Callender VD, Davis ECA. Review of acne in ethnic skin
pathogenesis, clinical manifestations, and management strategies. J
Clin Aesthet Dermatol 2010;3:24-38.
5. JeremyAH, HollandDB, RobertsSG, ThomsonKF, CunliffeWJ.
Inflammatory events are involved in acne lesion initiation. J Invest
Dermatol 2003;121:20-7.
6. JordanR, CumminsC, BurlsA. Laser resurfacing of the skin for
the improvement of facial acne scarring: a systematic review of the
evidence. Br J Dermatol 2000;142:413-23.
7. Callender VD. Acne in ethnic skin: special considerations for
therapy. Dermatol Ther 2004;17:184-95.
8. TaylorSC, Cook-BoldenF, RahmanZ, StrachanD. Acne vulgaris
in skin of color. J Am Acad Dermatol 2002;46:S98-106.
9. Halder RM, Holmes YC, Bridgeman-Shah S, Kligman AM. A
clinicohistopathologic study of acne vulgaris in black females
(abstract). J Invest Dermatol 1996;106:888.
10. Sardana K, GargVK, Arora P, KhuranaN. Histological validity
and clinical evidence for use of fractional lasers for acne scars. J
Cutan Aesthet Surg 2012;5:75-90.
11. Kligman AM, Mills OH Jr. Acne cosmetica. Arch Dermatol
1972;106:843-50.
12. RiveraAE. Acne scarring: a review and current treatment modalities.
J Am Acad Dermatol 2008;59:659-76.
13. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR.
Fractional photothermolysis: a new concept for cutaneous
remodeling using microscopic patterns of thermal injury. Lasers
Surg Med 2004;34:426-38.
14. LeeSJ, ChoiMJ, ChungWS, ChoSB. Targeted laser reconstruction
of skin scars using 10600-nm carbon dioxide fractional laser. J
Cosmet Laser Ther 2012;14:87-8.
15. Walgrave S, Zelickson B, Childs J, Altshuler G, Erofeev A,
Yaroslavsky I, etal. Pilot investigation of the correlation between
histological and clinical effects of infrared fractional resurfacing.
Aesthetic Plast Surg 2011;35:31-42.
16. Trelles MA, Shohat M, Urdiales F. Safe and effective one-session
fractional skin resurfacing using a carbon dioxide laser device in
super-pulse mode: a clinical and histologic study facing lasers.
Dermatol Surg 2008;34:1443-53.
17. Susan W, Brian BC, Gregory A, Andrei E, Ilya Y. Fractional
photothermolysis: a novel aesthetic laser surgery modality. Dermatol
Surg 2007;33:525-34.
18. JungJY, LeeJH, RyuDJ, LeeSJ, BangD, ChoSB. Lower-fluence,
higher-density versus higher-fluence, lower-density treatment with
a 10,600-nm carbon dioxide fractional laser system: a split-face,
evaluator-blinded study. Dermatol Surg 2010;36:2022-9.
19. MajidI, ImranS. Fractional CO2 laser resurfacing as monotherapy
in the treatment of atrophic facial acne scars. J Cutan Aesthet Surg
2014;7:87-92.
20. ChapasAM, BrightmanL, SukalS, HaleE, DanielD, BernsteinLJ,
etal. Successful treatment of acneiform scarring with CO2 ablative
fractional resurfacing. Lasers Surg Med 2008;40:381-6.
21. Manuskiatti W, Triwongwaranat D, Varothai S, Eimpunth S,
Wanitphakdeedecha R. Efficacy and safety of a carbon-dioxide
ablative fractional resurfacing device for treatment of atrophic acne
scars in Asians. J Am Acad Dermatol 2010;63:274-83.
22. Cho SB, LeeSJ, Kang JM, Kim YK, Chung WS, Oh SH. The
efficacy and safety of 10,600-nm carbon dioxide fractional laser for
acne scars in Asian patients. Dermatol Surg 2009;35:1955-61.
23. Hedelund L, Haak CS, Togsverd-Bo K, Bogh MK, Bjerring P,
Haedersdal M. Fractional CO2 laser resurfacing for atrophic
acne scars: a randomized controlled trial with blinded response
evaluation. Lasers Surg Med 2012;44:447-52.
24. Asilian A, Salimi E, Faghihi G, Dehghani F, Tajmirriahi N,
HosseiniSM. Comparison of Q-switched 1064-nm Nd:YAG laser
and fractional CO2 laser efficacies on improvement of atrophic facial
acne scar. J Res Med Sci 2011;16:1189-95.
25. Alster TS, Tanzi EL, Lazarus M. The use of fractional laser
photothermolysis for the treatment of atrophic scars. Dermatol Surg
2007;33:295-9.
26. Alam M, Omura N, Kaminer MS. Subcision for acne scarring:
technique and outcomes in 40 patients. Dermatol Surg 2005;31:310-
7; discussion 317.
27. OrentreichDS, OrentreichN. Subcutaneous incisionless (subcision)
surgery for the correction of depressed scars and wrinkles. Dermatol
Surg 1995;21:543-9.
28. NilforoushzadehM, LotfiE, NickkholghE, SalehiB, ShokraniM.
Can subcision with the cannula be an acceptable alternative method
in treatment of acne scars? Med Arch 2015;69:384-6.
29. ChandrashekarB, NandiniA. Acne scar subcision. J Cutan Aesthet
Surg 2010;3:125-6.
30. KangWH, KimYJ, PyoWS, ParkSJ, KimJH. Atrophic acne scar
treatment using triple combination therapy: dot peeling, subcision
and fractional laser. J Cosmet Laser Ther 2009;11:212-5.
31. KimS, ChoKH. Clinical trial of dual treatment with an ablative
fractional laser and a nonablative laser for the treatment of acne
scars in Asian patients. Dermatol Surg 2009;35:1089-98.
32. Ortiz AE, Tremaine AM, Zachary CB. Long-term efficacy of a
fractional resurfacing device. Lasers Surg Med 2010;42:168-70.
33. AlsousouJ, AliA, WillettK, HarrisonP. The role of platelet-rich
plasma in tissue regeneration. Platelets 2013;24:173-82.
34. Na JI, ChoiJW, Choi HR, Jeong JB, Park KC, Youn SW, et al.
Rapid healing and reduced erythema after ablative fractional
carbon dioxide laser resurfacing combined with the application of
autologous platelet-rich plasma. Dermatol Surg 2011;37:463-8.
35. Alves R, Grimalt R. A review of platelet-rich plasma: history,
biology, mechanism of action, and classification. Skin Appendage
Disord 2018;4:18-24.
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
Arsiwala and Desai: Fractional carbon dioxide laser for acne scars
94 94 Journal of Cutaneous and Aesthetic Surgery ¦ Volume 12 ¦ Issue 2 ¦ April-June 2019
36. Mahajan PV, Abbasi J, Subramanian S, Parad SC, Danke A.
Regenerative medicine using platelet-rich plasma and stem cells in
atrophic acne scars: a case report. J Cosmo Trichol 2017;3:2.
37. Faghihi G, Keyvan S, Asilian A, Nouraei S, Behfar S,
Nilforoushzadeh MA. Efficacy of autologous platelet-rich
plasma combined with fractional ablative carbon dioxide
resurfacing laser in treatment of facial atrophic acne scars: a
split-face randomized clinical trial. Indian J Dermatol Venereol
Leprol 2016;82:162-8.
38. ShinMK, LeeJH, Lee SJ, KimNI. Platelet-rich plasma combined
with fractional laser therapy for skin rejuvenation. Dermatol Surg
2012;38:623-30.
39. Abdel Aal AM, Ibrahim IM, Sami NA, Abdel Kareem IM.
Evaluation of autologous platelet-rich plasma plus ablative carbon
dioxide fractional laser in the treatment of acne scars. J Cosmet
Laser Ther 2018;20:106-13.
40. Garg S, Baveja S. Combination therapy in the management of
atrophic acne scars. J Cutan Aesthet Surg 2014;7:18-23.
41. GawdatHI, HegazyRA, FawzyMM, FathyM. Autologous platelet
rich plasma: topical versus intradermal after fractional ablative
carbon dioxide laser treatment of atrophic acne scars. Dermatol
Surg 2014;40:152-61.
42. RubensteinR, RoenigkHH Jr, Stegman SJ, HankeCW. Atypical
keloids after dermabrasion of patients taking isotretinoin. J Am
Acad Dermatol 1986;15:280-5.
43. KatzBE, MacFarlaneDF. Atypical facial scarring after isotretinoin
therapy in a patient with previous dermabrasion. J Am Acad
Dermatol 1994;30:852-3.
44. Mysore V, Mahadevappa OH, Barua S, Majid I, Viswanath V,
BhatRM, etal. Standard guidelines of care: performing procedures
in patients on or recently administered with isotretinoin. J Cutan
Aesthet Surg 2017;10:186-94.
[Downloaded free from http://www.jcasonline.com on Tuesday, August 6, 2019, IP: 186.28.54.154]
... Priming is defined as a substance that prepares the skin for use. Priming the skin prior to an invasive intervention for achieving an optimal result has been studied (34)(35)(36)(37)(38)(39)(40). However, the concept of preemptively priming the skin prior to injury has not been thoroughly evaluated. ...
... Several studies support the concept of pre-emptive priming of skin prior to cutaneous injury (34)(35)(36)(37)(38)(39). For instance, research on the treatment of pigmented acne scars by ablative laser therapy advocates the use of priming agents to reduce wound healing time, decrease the risk of post-inflammatory hyperpigmentation and provide ultraviolet damage protection (34). ...
... Several studies support the concept of pre-emptive priming of skin prior to cutaneous injury (34)(35)(36)(37)(38)(39). For instance, research on the treatment of pigmented acne scars by ablative laser therapy advocates the use of priming agents to reduce wound healing time, decrease the risk of post-inflammatory hyperpigmentation and provide ultraviolet damage protection (34). Additionally, radiotherapy has been used as an adjuvant therapy for the treatment of keloid scarring both prior to extralesional excision and post-surgery and this has been shown to lead to lower recurrence rates (73). ...
Article
Full-text available
Inflammation plays an active role during the wound healing process. There is a direct association between the extent of injury as well as inflammation and the amount of subsequent cutaneous scarring. Evidence to date demonstrates that high levels of inflammation are associated with excessive dermal scarring and formation of abnormal pathological scars such as keloids and hypertrophic scars. In view of the multiple important cell types being involved in the inflammatory process and their influence on the extent of scar formation, many scar therapies should aim to target these cells in order to control inflammation and by association help improve scar outcome. However, most current treatment strategies for the management of a newly formed skin scar often adopt a watch-and-wait approach prior to commencing targeted anti-inflammatory therapy. Moreover, most of these therapies have been evaluated in the remodelling phase of wound healing and the evaluation of anti-inflammatory treatments at earlier stages of healing have not been fully explored and remain limited. Taken together, in order to minimise the risk of developing a poor scar outcome, it is clear that adopting an early intervention prior to skin injury would be optimal, however, the concept of pre-emptively priming the skin prior to injury has not yet been thoroughly evaluated. Therefore, the aim of this review was to evaluate the available literature regarding scar therapies that aim to target inflammation which are commenced prior to when a scar is formed or immediately after injury, with a particular focus on the role of pre-emptive priming of skin prior to injury in order to control inflammation for the prevention of poor scarring outcome.
... There have been a lack of studies using these modalities for the prevention of scarring prior to injury, however, in vitro studies have demonstrated transdermal patches have the potential to inhibit hypertrophic scar formation [7][8][9]. Some recent studies support the concept of priming the skin prior to an invasive intervention for achieving an optimal result [10][11][12][13][14][15]. However, the concept of pre-emptively priming the skin prior to surgically induced injury has not been thoroughly evaluated. ...
... Several studies support the concept of pre-emptive priming of skin. For instance, research on the treatment of pigmented acne scars by ablative laser therapy advocates the use of priming agents to reduce wound healing time, decrease the risk of post-inflammatory hyperpigmentation and provide ultraviolet damage protection [10]. Resurfacing of scars using fractional CO2 laser with early interventional treatment can reduce scar formation [11]. ...
Article
Full-text available
The concept of pre-emptive priming of skin pre-surgery offers a novel approach in optimizing cutaneous scarring outcome. We previously showed an anti-scarring topical (epigallocatechin-3-gallate (EGCG)) is effective in improving skin scarring when applied post-surgery. The objective was to deliver an active compound at the optimal time in order to maximize its impact and improve cutaneous scarring. Therefore, pre-emptive application of anti-scarring topical pre-surgery compared with post-surgery can potentially be superior on scarring outcome. This double-blinded randomized placebo-controlled trial compares the effects of pre-emptive priming of skin with an anti-scarring topical pre-surgery versus post-surgery. Healthy volunteers (n = 40) were split into 4-groups; each undergoing different modes of application versus placebo: Group-1 = priming (7Days) pre-injury, Group-2 = priming (3D) pre-injury, Group-3 = immediate (0D) day-of-injury, Group-4 = delayed application (14D) post-injury. Excisional skin-biopsies in upper-arms were evaluated weekly with multiple quantitative devices over 8-weeks. Histological, immunohistochemical, mRNA sequencing and QRT-PCR studies were performed on tissue-biopsies. EGCG reduced mast cells at weeks-4 and 8 by gene and protein analyses (p < 0.01). Group 1 was superior to other groups (p < 0.01) in both clinical (blood flow) and laboratory parameters (elastin and immune marker expression). Additionally, there was down-regulation of angiogenic-markers by mRNA-sequencing and of CD31 and VEGF-A at weeks-4 and 8 (p < 0.01) by immunohistochemistry and at week-4 (p < 0.05) by QRT-PCR. EGCG increased antioxidant levels (HO-1) at week-4 (p < 0.01) plus elastin at week-8 (p < 0.01). In conclusion, pre-emptive priming of skin pre-injury has significant beneficial effects on surgically induced skin scarring shown by reducing mast cells, blood flow and angiogenesis plus increasing elastin content. This clinical trial was registered with ISRCTN (ISRCTN70155584).
... Acne scars come in a variety of shapes and depths and can be treated with a combination of treatments to achieve the satisfying result. The gold standard for the treatment of atrophic scars is the ablative fractional carbon dioxide (FCO 2 ) laser [8]. It induces the reepithelialization of keratinocytes and the production and rearrangement of collagen in the dermal tissue by creating micro-columnar vaporization zones and thermally coagulated necrotic zones in the tissue [9]. ...
Article
Full-text available
Fractional carbon dioxide (CO2) laser combined with subcision has been widely used for the clinical treatment, but the efficacy of the combined therapy on three types of atrophic acne scars remains unreported. This retrospective study analyzed the clinical data of 413 patients with atrophic acne scars, treated with fractional CO2 laser combined with subcision in the combined group and with fractional CO2 laser in the control group. The treatment efficacy was evaluated by the Investigator's Global Assessment (IGA) and the Échelle d'évaluation clinique des cicatrices d'acné (ECCA). We reported adverse reactions such as erythema, lump, skin sensitivity, acne recurrence, and hyperpigmentation that occurred in both treatment groups. The treatment efficiency of the combined group was significantly higher than that of the control group (P < 0.001). Among the three subtypes of atrophic acne scars, the ECCA scores in the combined group of boxcar-type and rolling-type scars after treatment were lower than those in the control group (P = 0.041, P < 0.001, respectively), and no statistical difference in scores between the two groups for icepick-type scars was seen (P = 0.062). There was no statistical difference in adverse reactions between the two groups (P = 0.361). Fractional CO2 laser combined with subcision is more effective than fractional CO2 laser in the treatment of boxcar-type and rolling-type scars, but there is no significant difference in the treatment of icepick-type scars.
... 8 Ablative fractional carbon dioxide (FCO 2 ) laser has been proved as the gold standard modality for the management of moderate to severe atrophic acne scars. 9,10 Although the laser has shown a great clinical improvement, it has some major concerns that limit the widespread use of the procedure. Platelet-rich plasma (PRP) is a plasma liquid processed from autologous serum that is highly concentrate with platelets and a variety of growth factors that activates and accelerates wound healing cascade stimulating collagen synthesis and neoangiogenesis. ...
Article
Full-text available
Background: Atrophic acne scars are the most common cutaneous seqaule of acne vulgaris, representing 80-90% of all acne scars. Ablative fractional carbon dioxide (FCO2) laser is the gold standard treatment for atrophic scars. Additionally, platelet-rich plasma (PRP) is suggested to accelerate the healing process and collagen synthesis. The aim of the present systematic review and meta-analysis was to determine the efficacy and safety of PRP combined with Ablative FCO2 laser in the treatment of moderate to severe atrophic acne scars. Methods: Randomized controlled trials (RCTs) that have compared PRP in combination with ablative FCO2 laser to ablative FCO2 laser alone with respect to the efficacy and safety measures were included. We have systematically explored Embase, Medline, and CENTRAL databases via Ovid. The outcomes that our systematic review saught to evaluate were clinical improvement, patient satisfaction, and Goodman and Baron's qualitative acne scar score. The dichotomous outcomes were presented as odds ratio (OR) while the continuous outcomes were presented as standardized mean difference (SMD). Results: 11 RCTs that represents 313 participants were included. The combined use of laser and PRP showed a statistically significant clinical improvement and patient satisfaction compared to the use of laser alone (OR=2.56, 95% CI 1.37 to 4.78 and OR=3.38, 95% CI 1.80 to 6.34, respectively). Also, a significant improvement in Goodman and Baron's score was achieved by combining PRP with laser (SMD = -0.40, 95% CI -0.65 to -0.14). Conclusion: The combined treatment of laser and PRP was highly synergistic, effective, and safe in treating moderate to severe atrophic acne scars. This article is protected by copyright. All rights reserved.
... The former includes anti-acne agents, chemical peels, microneedling, ablative and non-ablative fractional and nonfractional lasers, and microfused ultrasound alone or associated with fractional CO 2 laser resurfacing. [7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25] The latter include subcision. [26][27][28] Platelet-rich plasma has been employed as noninvasive procedure for atrophic acne scar. ...
Article
Background Managing acne scars is a challenge and therapies are divided into nonsurgical and surgical. Highly Purified Technology Polynucleotides, PN-HPT™ are a compound which contains a mixture of DNA polymers of different lengths. Numerous studies have shown that PN-HPT™ also serves as an energy source, thus influencing cellular growth and cells vitality. Objectives We aimed assessed the improvement in dermal quality and acne scars after PN-HPT™ versus placebo according to Antera 3D® and the patient responses to PSQ after a comparison of pretreatment and posttreatment photographs at 1 and 3 months. Methods We Included women aged 30-50 years old with grade 3-4 moderate-to-severe atrophic scars according to the Goodman classification; nonsmokers; had not had active acne during the past 5 years. Ten patients (PN-HPT™ group) were treated with 4.0 ml of PN-HPT™, and ten patients (control) were treated with 4.0 ml of normal saline. All medical treatments were performed in a double blinded manner; neither the injection doctor nor the patient knew if the PN-HPT™ or the placebo was being administered. Results Twenty women fit the inclusion criteria were enrolled in this study. Only patients in PN-HPT™ group improved significantly at 1 and 3 months after treatment compared to baseline. Conclusions Our prospective and randomized study showed that PN-HPT™ in monotherapy was safe and effective treatment for atrophic scar acne when compared with placebo. Prospective and randomized studies will be necessary to investigate the clinical effectiveness in a larger cohort of patients and for a longer follow-up.
Article
Significance: Laser use has become part of the gold standard of treatment as an effective adjuvant in multimodal therapy for pathologic scarring caused by burns, trauma, acne, and surgery, as well as vascular anomalies. Understanding indications and applications for laser therapy is essential for physicians to improve patient outcomes. Recent Advances: Since the 1980s, the medical use of lasers has continuously evolved with improvements in technology. Novel lasers and fractionated technologies are currently being studied in the hopes to improve treatment efficacy, while reducing complications. Recent advancements include acne treatment with novel picosecond lasers, new hypertrophic scar therapies with simultaneous laser and intense pulsed light use, and novel systems such as lasers with intralesional optical fiber delivery devices. In addition, optimizing the timing of laser therapy and its use in multimodal treatments continue to advance the field of photothermolysis. Critical Issues: Selecting the correct laser for a given indication is the fundamental decision when choosing a laser balancing effective treatment with minimal complications. This article covers the principles of laser therapy, the preferred lasers used for the treatment of scarring and vascular anomalies, and discusses the current evidence behind these laser choices. Future Directions: To optimize laser therapy, larger randomized control trials and split scar studies are needed. Continued advancement through better randomized controlled studies will help to improve patient outcomes on a broader scale.
Article
Zusammenfassung Fortschritte in der Lasertechnologie haben es in letzter Zeit ermöglicht, Textur, Erscheinungsbild und Elastizität der Haut bei Aknenarben zu verbessern. Es gibt allerdings noch keine vergleichenden Studien zu den gebräuchlichsten fraktionierten Lasersystemen bei Aknenarben. Das Ziel dieser Metaanalyse ist der Vergleich der klinischen Ergebnisse der Behandlung von Aknenarben mit Erbium-Laser oder CO2-Laser. Dazu wurden die Datenbanken PUBMED, EMBASE und Cochrane Library herangezogen. Es wurden die Verbesserung der Narben nach Beurteilung durch die Untersucher sowie durch die Patienten verglichen. Fünf Studien wurden eingeschlossen. Die Narben-Verbesserung war durch beide Laser-Behandlungen ähnlich, sowohl nach Beurteilung durch die Untersucher (RR: 0,60 95 %-KI: 0,35–1,02) als auch durch die Patienten (RR: 0,99 95 %-KI: 0,79–1,25). Nach Ausschluss von Studien mit hohem Verzerrungsrisiko durch Sensitivitätsanalyse war der CO2-Laser dem Erbium-Laser überlegen (RR: 0,47 95 %-KI: 0,24–0,93). Die Subgruppen-Analyse konnte allerdings keine signifikante Überlegenheit des CO2-Lasers gegenüber dem nichtablativen (RR: 0,65 95 %-KI: 0,34–1,24) oder dem ablativen Erbium-Laser (RR: 0,60 95 %-KI: 0,35–1,02) bestätigen. Nach Einschätzung der Untersucher war das klinische Ansprechen auf den CO2-Laser im Vergleich zum Erbium-Laser geringfügig besser. Insgesamt fanden sich keine wesentlichen Unterschiede in der Effektivität der beiden Laser-Technologien. Die beiden Resurfacing-Technologien könnten sich jedoch ergänzen, da sie Stärken bei unterschiedlichen klinischen Problemen zeigen.
Article
Recent advances in laser technology allowed the development of systems that improve texture, appearance and pliability of skin in acne scars (AS). Currently, comprehensive comparative studies on the efficacy of the most commonly used fractional systems in AS are lacking. Thus, the aim of this work was to appraise and compare the clinical response to erbium versus CO2 lasers in AS in the form of a meta‐analysis. The databases MEDLINE, EMBASE, Cochrane library were searched. Main clinical outcomes were investigator‐reported scar improvement and participant‐reported scar improvement. Five studies were included in this meta‐analysis. Scar improvement was similar for both types of laser in terms of investigator‐reported scar improvement (RR: 0.60 95 % CI: 0.35–1.02) and participant‐reported scar improvement (RR: 0.99 95 % CI: 0.79–1.25). A sensitivity analysis that excluded studies with high risk of bias found the CO2 lasers to be superior to the erbium lasers (RR: 0.47 95 % CI: 0.24–0.93): However, the subgroup analysis showed the CO2 laser not to be significantly different from either the non‐ablative erbium (RR: 0.65 95 % CI: 0.34–1.24) or the ablative erbium laser (RR: 0.60 95 % CI: 0.35–1.02). The CO2 laser produced a slightly greater clinical response compared to the erbium lasers based on the physician’s assessment. Overall, the two devices do not differ largely in terms of efficacy but may be complementary, with each resurfacing laser better suited for different clinical tasks.
Article
Background Hypertrophic scars are devastating outcomes of severe burn injuries, producing physical and mental burdens. Adequate treatment is of benefit to relieve these burdens. Laser therapy has shown scar reducing effects. In this study, we compared outcomes after combination of two different lasers or single laser treatment to treat severe hypertrophic burn scars. Methods Forty patients with hypertrophic burn scars were included in one of two therapeutic groups: continuous wave CO2 laser and fractional ablative CO2 laser group (group 1, n = 20) or fractional ablative CO2 laser alone group (group 2, n = 20). Hypertrophic scars were evaluated by the observer-rated Vancouver Scar Scale (VSS) before and after treatment and by patient-completed questionnaires after treatment. Comparative analyses were performed before and after treatment, and time-dependent improvement was also analyzed. Results Forty patients (54 hypertrophic scars) completed the laser treatment protocols. Group 1 exhibited significantly more improvement in VSS vascularity, pliability, and height indices than group 2 (p < 0.05). Time-dependent analysis of total VSS scores suggested that group 1 experienced more improvement during a shorter treatment period (p < 0.05). For patient-reported outcomes, group 1 noted better grades than group 2 in four indices, namely scar appearance, scar thickness, pain, and pruritus (p < 0.05). Conclusion Effective scar reduction was achieved using combination laser treatment, with significant improvement in multiple observer- and patient-reported outcomes. The shorter treatment period of the combination method can be a merit, as prolonged hypertrophic scars may increase morbidity. Nonetheless, cautious treatment protocols are necessary to avoid undesirable sequelae related to laser application.
Article
Full-text available
Background: Currently, the standard protocol regarding the performance of procedures on patients receiving or having recently received isotretinoin (13-cis-retinoic acid) states that the procedures should not be performed. The recommendations in standard books and drug insert require discontinuation of isotretinoin for 6 months before performing cosmetic procedures, including waxing, dermabrasion, chemical peels, laser procedures, or incisional and excisional cold-steel surgery. These recommendations have been followed for over two decades despite little evidence for the stated increased risk of scarring. Objective: The Association of Cutaneous Surgeons (I) constituted a task force to review the evidence and to recommend consensus guidelines regarding the safety of skin procedures, including resurfacing, energy-device treatments, and dermatosurgical procedures in patients with concurrent or recent isotretinoin administration. Materials and methods: Data were extracted from the literature through a PubMed search using the keywords "isotretinoin," "safety," "scarring," "keloids," "hypertrophic scarring," and "pigmentation." The evidence was then labeled and circulated to all members of task force for review. Results: The task force is of the opinion that there is insufficient evidence to support the current protocol of avoiding and delaying treatments in the patient group under consideration and recommends that the current practice should be discontinued. The task force concludes that performing procedures such as laser hair removal, fractional lasers for aging and acne scarring, lasers for pigmented skin lesions, fractional radio-frequency microneedling, superficial and medium-depth peels, microdermabrasion, dermaroller, biopsies, radio-frequency ablation, and superficial excisions is safe in patients with concurrent or recent isotretinoin administration.
Article
Full-text available
Platelet-rich plasma (PRP) is currently used in different medical fields. The interest in the application of PRP in dermatology has recently increased. It is being used in several different applications as in tissue regeneration, wound healing, scar revision, skin rejuvenating effects, and alopecia. PRP is a biological product defined as a portion of the plasma fraction of autologous blood with a platelet concentration above the baseline. It is obtained from the blood of patients collected before centrifugation. The knowledge of the biology, mechanism of action, and classification of the PRP should help clinicians better understand this new therapy and to easily sort and interpret the data available in the literature regarding PRP. In this review, we try to provide useful information for a better understanding of what should and should not be treated with PRP.
Article
Full-text available
Background: Autologous platelet-rich plasma has recently attracted significant attention throughout the medical field for its wound-healing ability. Aims: This study was conducted to investigate the potential of platelet-rich plasma combined with fractional laser therapy in the treatment of acne scarring. Methods: Sixteen patients (12 women and 4 men) who underwent split-face therapy were analyzed in this study. They received ablative fractional carbon dioxide laser combined with intradermal platelet-rich plasma treatment on one half of their face and ablative fractional carbon dioxide laser with intradermal normal saline on the other half. The injections were administered immediately after laser therapy. The treatment sessions were repeated after an interval of one month. The clinical response was assessed based on patient satisfaction and the objective evaluation of serial photographs by two blinded dermatologists at baseline, 1 month after the first treatment session and 4 months after the second. The adverse effects including erythema and edema were scored by participants on days 0, 2, 4, 6, 8, 15 and 30 after each session. Results: Overall clinical improvement of acne scars was higher on the platelet-rich plasma-fractional carbon dioxide laser treated side but the difference was not statistically significant either 1 month after the first treatment session (P = 0.15) or 4 months after the second (P = 0.23). In addition, adverse effects (erythema and edema) on the platelet-rich plasma-fractional carbon dioxide laser-treated side were more severe and of longer duration. Limitations: Small sample size, absence of all skin phototypes within the study group and lack of objective methods for the evaluation of response to treatment and adverse effects were the limitations. Conclusion: This study demonstrated that adding platelet-rich plasma to fractional carbon dioxide laser treatment did not produce any statistically significant synergistic effects and also resulted in more severe side effects and longer downtime.
Article
Full-text available
BACKGROUND AND OBJECTIVES: Most people who experience the acne suffer from damage under the surface of their skin which causes saucer-like depressions or pits on their skin. Sometimes the skin loses its underlying support and develops fibrous bands of tissue between the skin and subcutaneous layer, which pull on the epidermis and cause a wavy texture called as rolling scar. Treatment of acne scars is a therapeutic challenge that may require multiple modalities. Subcision is a procedure that has been reported as a beneficial method in the treatment of rolling acne scars. Although Subcision is a valuable method, its efficacy is mild to moderate because of the high recurrence rate and patients dissatisfaction due to some side effects include post procedure inflammation.
Article
Full-text available
Background: While laser resurfacing remains the most effective treatment option for atrophic acne scars, the high incidence of post-treatment adverse effects limits its use. Fractional laser photothermolysis attempts to overcome these limitations of laser resurfacing by creating microscopic zones of injury to the dermis with skip areas in between. Aim: The aim of the present study is to assess the efficacy and safety of fractional CO 2 laser resurfacing in atrophic facial acne scars. Materials and Methods: Sixty patients with moderate to severe atrophic facial acne scars were treated with 3-4 sessions of fractional CO 2 laser resurfacing at 6-week intervals. The therapeutic response to treatment was assessed at each follow up visit and then finally 6 months after the last laser session using a quartile grading scale. Response to treatment was labelled as ′excellent′ if there was >50% improvement in scar appearance and texture of skin on the grading scale while 25-50% response and
Article
Full-text available
Atrophic acne scars are difficult to treat. The demand for less invasive but highly effective treatment for scars is growing. To assess the efficacy of combination therapy using subcision, microneedling and 15% trichloroacetic acid (TCA) peel in the management of atrophic scars. Fifty patients with atrophic acne scars were graded using Goodman and Baron Qualitative grading. After subcision, dermaroller and 15% TCA peel were performed alternatively at 2-weeks interval for a total of 6 sessions of each. Grading of acne scar photographs was done pretreatment and 1 month after last procedure. Patients own evaluation of improvement was assessed. Out of 16 patients with Grade 4 scars, 10 (62.5%) patients improved to Grade 2 and 6 (37.5%) patients improved to Grade 3 scars. Out of 22 patients with Grade 3 scars, 5 (22.7%) patients were left with no scars, 2 (9.1%) patients improved to Grade 1and 15 (68.2%) patients improved to Grade 2. All 11 (100%) patients with Grade 2 scars were left with no scars. There was high level of patient satisfaction. This combination has shown good results in treating not only Grade 2 but also severe Grade 4 and 3 scars.
Article
Introduction: Acne scar is a common distressing complication of acne vulgaris. CO2 laser resurfacing proved effective for treatment of such problem but the associated complications may limit its use. Platelet rich plasma (PRP) may increase the chance of favorable outcome. Aim of the work: To evaluate the synergistic effects of autologous PRP with fractional CO2 laser resurfacing in treatment of acne scars among Egyptian patients. Patients and method: This study included 30 patients suffering from post-acne scars. CO2 laser treatment was applied to both sides of the face followed by PRP injection for the right side. Evaluation was carried out through operating physicians, two blinded physicians as well as patient`s satisfaction. Result: The right side of the face (PRP treated side) achieved excellent improvement in 13.3% of patients while there was no excellent improvement on the left side. Conclusion: combination of fractional CO2 laser resurfacing and intradermal PRP was superior to CO2 laser alone for acne scar treatment.
Article
Atrophic scars are a common complication of acne. Many modalities are proposed but each does not yield satisfactory clinical outcomes. Thus, a new combination therapy is suggested that incorporates (i) dot peeling, the focal application and tattooing of higher trichloroacetic acid concentrations; (ii) subcision, the process by which there is separation of the acne scar from the underlying skin; and (iii) fractional laser irradiation. In this pilot study, the efficacy and safety of this method was investigated for the treatment of acne scars. Ten patients received this therapy for a year. Dot peeling and subcision were performed twice, 2-3 months apart and fractional laser irradiation was performed every 3-4 weeks. Outcomes were assessed using scar severity scores and patients' subjective ratings. Acne scarring improved in all of the patients completing this study. Acne scar severity scores decreased by a mean of 55.3%. Eighty percent of the patients felt significant or marked improvement. There were no significant complications at the treatment sites. It would appear that triple combination therapy is a safe and very effective combination treatment modality for a variety of atrophic acne scars.